ArticleScientific reports2021

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma.

Kamonlapat Supimon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.